BridgeBio Pharma at a glance
bridgebio.com- Founded 2015
- Ticker BBIO

BridgeBio Pharma
Join BridgeBio Pharma as Senior/Executive Director, Business Operations in a full-time capacity at our San Francisco headquarters (1800 Owens). This pivotal role shapes our Encaleret program's path to commercial success through strategic planning and cross-functional leadership.
The Opportunity
This is a compelling opportunity to drive business transformation within a pioneering biotech organization. You will architect strategic initiatives that directly advance our Encaleret program toward commercial success, combining financial acumen with leadership across multiple functional teams. Your impact spans market readiness planning, financial modeling, investor communications, and corporate partnerships—all designed to bring innovative therapies to patients with unmet medical needs.
Day-to-Day Responsibilities
- Develop and communicate comprehensive strategic plans that guide resource allocation and organizational priorities for the Encaleret program
- Build financial models, including discounted cash flow analyses, alongside market research on competitive therapeutics and patient epidemiology to inform program strategy
- Design and present executive-level materials for board presentations, investor meetings, and internal strategy sessions, synthesizing complex technical and commercial data into clear, actionable insights
- Work closely with R&D, regulatory affairs, finance, commercial, and operations teams to ensure integrated strategy development and execution
- Own budget planning and long-term product lifecycle management to support both near-term launch readiness and sustained commercial performance
- Research pricing strategies and reimbursement landscapes in collaboration with the commercial team to optimize market access
- Lead cross-functional initiatives related to product lifecycle planning, market expansion, and operational efficiency
What We're Looking For
- Master's degree or equivalent (MBA, MD, or Ph.D.) preferred
- 2–5 years of professional experience in management consulting (with life sciences background preferred), venture capital, investment banking, equity research, post-Series A funding, or operational roles within therapeutics organizations
- Strong foundation in financial modeling, particularly discounted cash flow (DCF) analysis
- Deep understanding of the drug development lifecycle from discovery through commercial execution, including the biotech operating model and competitive landscape
- Prior involvement in new product commercialization programs (a significant plus)
- Demonstrated scientific reasoning ability combined with exceptional communication and presentation skills
- Commitment to improving patient outcomes and advancing rare disease therapeutics
- Ability to synthesize technical and commercial information for diverse audiences—from scientific experts to investment professionals
About the Company
Since 2015, BridgeBio Pharma has reimagined drug discovery and development through a distinctive financial model that de-risks innovation. By consolidating promising early-stage research from academic centers under unified funding, we empower small, expert teams to move science forward without conventional constraints. Our mission centers on bridging groundbreaking discoveries to rare disease patients with unmet needs, working at speed to deliver transformative medicines. We foster a culture that celebrates curiosity, rigorous experimentation, and thoughtful technology adoption—including AI—to enhance decision-making and accelerate impact.
Next Steps
To apply, complete your application directly on this page, or you'll be redirected to the employer's application platform to finish submitting there.
To apply for this job please visit job-boards.greenhouse.io.
Terms used in this posting
- equity
- Ownership stake in the company, usually in the form of stock options or RSUs, offered in addition to salary.
Explore BridgeBio Pharma online
What people say about BridgeBio Pharma
Recent news
- 9 Green Days In A Row: BridgeBio Pharma Stock Is Up 14% - Trefis
- Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead - TradingView
- BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth - Zacks Investment Research
- BridgeBio Pharma’s SWOT analysis: stock gains momentum on pipeline strength - Investing.com
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’ - Fierce Pharma
Aggregated from public discussions and news; opinions are the authors’ own.
Working in San Francisco - 1800 Owens
🇺🇸 Relocation safety for US: Exercise Normal Caution — via Warnely, CC BY 4.0
National unemployment rate in US: 4.2% — via World Bank
Job details above are provided by the employer/source. The sections on this page are compiled from public data sources with AI assistance.
Accommodations: if you need a workplace accommodation to apply for or perform this job, see ADA.gov or EEOC.gov for guidance on your rights and how to request one.
Keep exploring on Get A Job.ai
Not quite the right fit? Your next opportunity is a click away.
- Browse all jobs
- More jobs by category
- Remote jobs you can do from anywhere
- Research typical pay for this role
- Set a job alert so new matches reach you first
- Upload your resume to apply faster
Hiring instead? Post a job and reach candidates searching right now.
